124 related articles for article (PubMed ID: 38379015)
1. Integrative ATAC-seq and RNA-seq analysis associated with diabetic nephropathy and identification of novel targets for treatment by dapagliflozin.
Shen J; Ying L; Wu J; Fang Y; Zhou W; Qi C; Gu L; Mou S; Yan Y; Tian M; Ni Z; Che X
Cell Biochem Funct; 2024 Mar; 42(2):e3943. PubMed ID: 38379015
[TBL] [Abstract][Full Text] [Related]
2. An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy.
Bai Z; Xie T; Liu T; Chen Z; Yu L; Zhang C; Luo J; Chen L; Zhao X; Xiao Y
Front Endocrinol (Lausanne); 2022; 13():967822. PubMed ID: 36213291
[TBL] [Abstract][Full Text] [Related]
3. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin Reduces Urinary Albumin Excretion by Downregulating the Expression of cAMP, MAPK, and cGMP-PKG Signaling Pathways Associated Genes.
Chen G; Wang H; Zhang W; Zhou J
Genet Test Mol Biomarkers; 2021 Oct; 25(10):627-637. PubMed ID: 34672772
[No Abstract] [Full Text] [Related]
5. Integrated analysis of ATAC-seq and RNA-seq reveals the transcriptional regulation network in SLE.
Wu J; Li Y; Feng D; Yu Y; Long H; Hu Z; Lu Q; Zhao M
Int Immunopharmacol; 2023 Mar; 116():109803. PubMed ID: 36738683
[TBL] [Abstract][Full Text] [Related]
6. Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes.
Wen L; Zhang Z; Peng R; Zhang L; Liu H; Peng H; Sun Y
J Cell Biochem; 2019 Oct; 120(10):17520-17533. PubMed ID: 31106482
[TBL] [Abstract][Full Text] [Related]
7. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
9. RNA-Seq Analysis of ceRNA-Related Networks in the Regulatory Metabolic Pathway of Mice with Diabetic Nephropathy Subjected to Empagliflozin Intervention.
Wu T; Zhang Z; Huang H; Wu X
Arch Esp Urol; 2023 Nov; 76(9):680-689. PubMed ID: 38053423
[TBL] [Abstract][Full Text] [Related]
10. RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models.
Yang H; Zhang Z; Peng R; Zhang L; Liu H; Wang X; Tian Y; Sun Y
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779731
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Analysis of Yeast Metabolic Cycle through Metabolic Network Models Reveals Superiority of Integrated ATAC-seq Data over RNA-seq Data.
Cesur MF; Çakır T; Pir P
mSystems; 2022 Jun; 7(3):e0134721. PubMed ID: 35695574
[TBL] [Abstract][Full Text] [Related]
12. Integrating ATAC-seq and RNA-seq Reveals the Dynamics of Chromatin Accessibility and Gene Expression in Apple Response to Drought.
Wang S; He J; Deng M; Wang C; Wang R; Yan J; Luo M; Ma F; Guan Q; Xu J
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232500
[TBL] [Abstract][Full Text] [Related]
13. Nephropathy in diabetic db/db mice is accelerated by high protein diet and improved by the SGLT2 inhibitor dapagliflozin.
Nørgaard SA; Briand F; Sand FW; Galsgaard ED; Søndergaard H; Sørensen DB; Sulpice T
Eur J Pharmacol; 2019 Oct; 860():172537. PubMed ID: 31310751
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
Terami N; Ogawa D; Tachibana H; Hatanaka T; Wada J; Nakatsuka A; Eguchi J; Horiguchi CS; Nishii N; Yamada H; Takei K; Makino H
PLoS One; 2014; 9(6):e100777. PubMed ID: 24960177
[TBL] [Abstract][Full Text] [Related]
15. Profile of Podocyte Translatome During Development of Type 2 and Type 1 Diabetic Nephropathy Using Podocyte-Specific TRAP mRNA RNA-seq.
Wang Y; Niu A; Pan Y; Cao S; Terker AS; Wang S; Fan X; Toth CL; Ramirez Solano MA; Michell DL; Contreras D; Allen RM; Zhu W; Sheng Q; Fogo AB; Vickers KC; Zhang MZ; Harris RC
Diabetes; 2021 Oct; 70(10):2377-2390. PubMed ID: 34233930
[TBL] [Abstract][Full Text] [Related]
16. Analysis of potential biomarkers for diabetic kidney disease based on single-cell RNA-sequencing integrated with a single-cell sequencing assay for transposase-accessible chromatin.
Shi Y; Guo Z; Liu F; Pan S; Gao D; Zhou S; Liu Z; Wang F; Liu D; Liu Z
Aging (Albany NY); 2023 Oct; 15(19):10681-10704. PubMed ID: 37827693
[TBL] [Abstract][Full Text] [Related]
17. Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db/db mice.
Wu J; Chen Y; Yang H; Gu L; Ni Z; Mou S; Shen J; Che X
Front Endocrinol (Lausanne); 2023; 14():1026040. PubMed ID: 36777358
[TBL] [Abstract][Full Text] [Related]
18. Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beads.
De Rop FV; Ismail JN; Bravo González-Blas C; Hulselmans GJ; Flerin CC; Janssens J; Theunis K; Christiaens VM; Wouters J; Marcassa G; de Wit J; Poovathingal S; Aerts S
Elife; 2022 Feb; 11():. PubMed ID: 35195064
[TBL] [Abstract][Full Text] [Related]
19. Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome.
Guo Z; Zhu Y; Xiao H; Dai R; Yang W; Xue W; Zhang X; Hao B; Liao S
Biol Res; 2023 Dec; 56(1):67. PubMed ID: 38066591
[TBL] [Abstract][Full Text] [Related]
20. Integration of ATAC-seq and RNA-seq analysis identifies key genes affecting intramuscular fat content in pigs.
Xu Z; Wu J; Zhou J; Zhang Y; Qiao M; Sun H; Li Z; Li L; Chen N; Oyelami FO; Peng X; Mei S
Front Nutr; 2022; 9():1016956. PubMed ID: 36276837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
